News
SPRC
1.460
-3.95%
-0.060
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 5d ago
Weekly Report: what happened at SPRC last week (1208-1212)?
Weekly Report · 5d ago
Weekly Report: what happened at SPRC last week (1201-1205)?
Weekly Report · 12/08 10:09
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 12/05 12:05
Why Ulta Beauty Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/05 09:53
SciSparc’s NeuroThera Labs Eyes Quantum Leap with New Acquisition
TipRanks · 12/02 21:29
NeuroThera to acquire 55% stake in quantum computing bio data company
TipRanks · 12/02 14:35
SciSparc's NeuroThera Labs To Acquire 55% Stake In Israeli Quantum Bio Data Company, Issuing Shares Equal To 40% of NeuroThera's Capital; No Financial Terms Disclosed
Benzinga · 12/02 14:31
*SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire 55% Equity Stake in a Quantum Algorithm Bio Data Analysis Co
Dow Jones · 12/02 14:30
NeuroThera Labs to Acquire Majority Stake in Quantum Bio Data Analysis Company
Reuters · 12/02 14:29
SCISPARC: NEUROTHERA LABS SIGNS NON-BINDING TERM SHEET TO ACQUIRE MAJORITY STAKE IN A QUANTUM ALGORITHM BIO DATA ANALYSIS COMPANY
Reuters · 12/02 14:29
SCISPARC LTD - NEUROTHERA TO BUY 55% EQUITY INTEREST IN TARGET COMPANY
Reuters · 12/02 14:29
Neurothera Labs to Acquire 55% Stake in Quantum Bio Data Company
Reuters · 12/02 13:05
SciSparc plans to enter GERD device market with IP portfolio acquisition
TipRanks · 12/01 13:45
BRIEF-Scisparc Plans On Entering The Multi-Billion-Dollar Gerd Device Market With Acquisition Of An Approved IP Portfolio
Reuters · 12/01 13:34
SciSparc Acquires MUSE System IP Portfolio from Xylo Technologies
Reuters · 12/01 13:32
SCISPARC LTD - TO ISSUE 19.99% SHARE CAPITAL TO XYLO
Reuters · 12/01 13:32
Weekly Report: what happened at SPRC last week (1124-1128)?
Weekly Report · 12/01 10:06
SciSparc Ltd. Announces $2.2 Million Securities Offering
TipRanks · 11/28 11:29
SciSparc Ltd. to Acquire Xylo’s Patents for Endoscopic Systems
TipRanks · 11/26 21:29
More
Webull provides a variety of real-time SPRC stock news. You can receive the latest news about Scisparc through multiple platforms. This information may help you make smarter investment decisions.
About SPRC
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.